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Abstract
The skeletal dysplasias are disorders of the bone and cartilage tissues. Similarly to humans, several dog breeds have been
reported to suffer from different types of genetic skeletal disorders. We have studied the molecular genetic background of
an autosomal recessive chondrodysplasia that affects the Norwegian Elkhound and Karelian Bear Dog breeds. The affected
dogs suffer from disproportionate short stature dwarfism of varying severity. Through a genome-wide approach, we
mapped the chondrodysplasia locus to a 2-Mb region on canine chromosome 17 in nine affected and nine healthy
Elkhounds (praw = 7.42610
26, pgenome-wide = 0.013). The associated locus contained a promising candidate gene, cartilage
specific integrin alpha 10 (ITGA10), and mutation screening of its 30 exons revealed a nonsense mutation in exon 16
(c.2083C.T; p.Arg695*) that segregated fully with the disease in both breeds (p = 2.5610223). A 24% mutation carrier
frequency was indicated in NEs and an 8% frequency in KBDs. The ITGA10 gene product, integrin receptor a10-subunit
combines into a collagen-binding a10b1 integrin receptor, which is expressed in cartilage chondrocytes and mediates
chondrocyte-matrix interactions during endochondral ossification. As a consequence of the nonsense mutation, the a10-
protein was not detected in the affected cartilage tissue. The canine phenotype highlights the importance of the a10b1
integrin in bone growth, and the large animal model could be utilized to further delineate its specific functions. Finally, this
study revealed a candidate gene for human chondrodysplasias and enabled the development of a genetic test for breeding
purposes to eradicate the disease from the two dog breeds.
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Introduction
The human skeletal dysplasias are rare disorders of varying
severity that present with abnormalities in the skeletal patterning,
development, growth and maintenance [1,2]. Majority has an
autosomal recessive or dominant inheritance pattern [3]. In the
most recent classification effort, over 450 distinct entities were
placed in the broad group of human genetic skeletal disorders, and
altogether 226 skeletal dysplasia genes were reported [3]. The
known causative genes, which explain 316 of the characterized
skeletal disorders [3], encode a variety of different proteins,
including extracellular matrix (ECM) components, enzymes, ion
channels, signal transducers and transcription factors [1,2,4,5].
Three general subgroups of skeletal dysplasia are commonly
recognized, although the clinical characteristics can overlap.
Osteodysplasia and chondrodysplasia are generalized disorders
of the bone and cartilage tissues, whereas the dysostoses affect
individual bones or group of bones [1]. Primary osteodysplasias
are characterized by altered bone mineral density and chron-
drodysplasias by abnormal endochondral ossification, which
affects the linear growth of bones and typically results in
disproportionate short stature [6,7]. Bone formation through
endochondral ossification takes place in the epiphyseal growth
plates of the long bones. The cartilaginous growth plates are
composed of ECM and linear columns of differentiating chon-
drocytes that are organized into zones of resting, proliferating,
mature and hypertrophied cells, subsequently replaced by
trabecular bone [8,9]. Disruptions in genes and proteins that
affect growth plate physiology have direct effects in endochodral
ossification and lead to various pathologies [4,9]. A significant
group of chondrodysplasia-causing genes constitute those that
code for cartilage ECM proteins, such as cartilage oligomeric
matrix protein (COMP), proteoglycans aggrecan and perlecan and
several different collagens [10–13]. Other examples of causative
genes include fibroblast growth factor receptor 3 (FGFR3) and
parathyroid hormone 1 receptor (PTHR1), which encode receptors
that regulate growth plate chondrocyte differentiation and
proliferation [14–17], and a sulfate transporter (SLC26A2), which
codes for a sulfate transporter that maintains adequate sulfation of
ECM proteoglycans [18–20].
In addition to humans, inherited chondrodysplasia occurs in the
pure-bred dog [21,22]. The population structure of modern dog
breeds is characterized by high inbreeding, severe bottlenecks and
isolation, all of which have increased the incidence of simple and
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complex inherited diseases [23,24]. As a result of the unique
population history, linkage disequilibrium is relatively long within
breeds, enabling genome-wide association studies (GWAS) to be
performed using small sample numbers [25,26]. Inherited
chondrodysplasia has been described in several breeds, including
the Alaskan Malamute [27–29], Norwegian Elkhound [30],
Figure 1. Chondrodysplastic and normal Norwegian Elkhounds and Karelian Bear Dogs. (A) A 5-year-old affected female Norwegian
Elkhound with chondrodysplasia (left) and a 3-year-old unaffected female Norwegian Elkhound (right). The height at withers was 42 cm for the
affected and 48 cm for the unaffected dog. (B) A 7-year-old affected male Elkhound with a height at withers of 38 cm. (C) A normal 5-month-old male
Karelian Bear Dog together with its severely affected and significantly smaller male littermate. (D) An adult, less severely affected Karelian Bear Dog
that is actively used in hunting. (E) The 5-month-old affected male puppy has prominent bilateral carpal valgus (arrows) and knock knees (genu
valgus) (arrowheads). The muscles of the pelvis and thigh are underdeveloped due to severe hip dysplasia. (F) The left forepaw of the 5-month-old
affected puppy. Outer digits are abnormally short (arrows). (G) The left forepaw (left) and the left hind paw (right) of an adult affected Elkhound.
Similarly to the Karelian Bear Dog, the outer digits are abnormally short in this affected dog (arrows).
doi:10.1371/journal.pone.0075621.g001
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Miniature Poodle [31] Samoyed [32], Labrador Retriever [33,34],
Scottish Deerhound [35], English Pointer [36], Great Pyrenees
[37] and the Irish Setter [38]. Autosomal recessive inheritance has
been proposed in Alaskan Malamutes [39], Great Pyrenees [37]
and Irish Setters [38]. The causative mutation is known in few
breeds but the majority of the phenotypes have an unknown
molecular genetic cause. Recently, a collagen type XI (COL11A2)
mutation was associated with mild chondrodysplasia in Labrador
Retrievers [40], and a sodium/sulfate cotransporter (SLC13A1)
mutation was shown to cause severe dwarfism in the Miniature
Poodle breed [41]. Furthermore, an oculo-skeletal dysplasia in
Samoyeds and Labrador Retrievers has been linked to recessive
collagen type IX mutations (COL9A2 and COL9A3, respectively)
[42]. In addition to being an anomalous phenotype, chondrodys-
plasia occurs in some breeds as a fixed, breed-defining trait [43–
47]. In a number of these breeds, the short-limb phenotype has
been shown to be due to an expressed fibroblast growth factor 4
(FGF4) retrogene [47].
The Norwegian Elkhound (NE) is a Nordic hunting breed that
suffers from disproportionate short-limbed dwarfism. The condi-
tion, which is caused by a generalized dysfunction in the
endochondral ossification process, has been clinically and histo-
logically characterized in the 1980’s [30]. The radiographic
findings in affected NEs include curved front limbs, carpal valgus,
shortening of vertebral bodies, delayed ossification of carpal bones
and increased metaphyseal width and flaring [30]. Growth plate
histology reveals several changes, which include unusual wide bars
of ECM, disorganized columnar structure and atypical large
chondrocytes with altered morphology [30]. The genetic back-
ground of the phenotype has not been studied before.
We report here our efforts to identify the gene mutation behind
NE chondrodysplasia. We successfully mapped the disease locus
through a genome-wide approach and identified a fully segregat-
ing nonsense mutation. We also show that the same recessive
mutation segregates with a similar short-limbed dwarfism in
another Nordic hunting breed, the Karelian Bear Dog (KBD),
supporting its causative nature. Our present findings have both
scientific and practical implications on bone biology and canine
breeding programs, respectively.
Results
Pedigree Analysis and Radiographic Examinations Reveal
a Recessive Condition with Variable Skeletal Changes
Our research group was approached by Finnish NE breeders
that were concerned about the relatively high occurrence of short-
legged dwarf dogs in the breed. The affected NEs were viable with
normal cognition but had approximately 10 cm shorter limbs than
normal (Figure 1A and B). In order to verify the dwarf
phenotype, NE owners were asked to provide three size
parameters as a part of the sampling effort: height at withers,
forearm length and the length from wrist to paw (metacarpal and
carpal bones). The size measurements were obtained from nine
adult affected NEs, comprising six males and three females
and from 25 unaffected adult NEs, comprising 14 males and 11
females (Table 1). The mean height at withers and the length
of the forearm differed significantly between the affected
and unaffected groups in both males (pwithers = 0.001 and
pforearm = 0.000, two-tailed Mann-Whitney U-test) and females
(pwithers = 0.000 and pforearm = 0.002, two-tailed t-test) (Figure 2A
and B). No statistically significant difference was found in the
length of metacarpal and carpal bones in either sex (Figure 2C).
Blood samples were obtained from altogether 13 adult affected
NEs from Finland and four adult affected NEs from the United
States. The pedigrees established around the known affected NEs
suggested an autosomal recessive mode of inheritance (Figure 3A
and B). All the parents of affected dogs were normal height dogs
and both genders were affected.
As the study had progressed with NEs, it came to our attention
that a similar type of dwarfism occurred in another Nordic breed,
the KBD (Figure 1C–E). At least three different litters with
affected dogs were reported in the KBDs. All affected litters could
be traced back to a single male (arrow) that lived in the 1980’s and
sired over 450 puppies in its lifetime (Figure 3C). There was a
strong suspicion within the breed that this popular sire had not
been a purebred KBD but a NE-KBD mix, which suggested that
the two breeds might share a causative mutation. As in NEs, the
mode of inheritance in KBDs was consistent with a recessive
model since the parents were unaffected (Figure 3C). Altogether
four affected KBDs were sampled for this study, three of which
were 5-month-old juvenile dogs from the same litter and the fourth
was an adult affected dog.
A 3-year-old affected male NE and affected and healthy 5-
month-old male KBD littermates (Figure 1C) volunteered for a
clinical study and were referred to a radiographic examination.
On outward appearance, the affected NE had short stature but no
ambulatory difficulties, whereas the juvenile affected KBD
preferred sitting down to standing up as it suffered from hip
dysplasia and subsequent underdevelopment of pelvis and thigh
muscles (Figure 1E). In addition, the affected KBD had
abnormally developed digits, a condition, which was also present
in a few affected NEs (Figure 1F and G).
Radiographs of limbs, spine and skull were obtained from all
three dogs. The adult dwarf NE was skeletally less affected than
the juvenile KBD (Figure 4). The radii of the affected NE were
slightly bowed cranially (Figure 4C), the epiphyses were wider
and the thorax shallower than normally but otherwise the skeleton
appeared to be within normal limits. The radiological findings in
the affected KBD were more pronounced. Compared to the
narrow and even growth plates of the normal littermate, the
growth plates of the affected KBD were wide and irregular and the
metaphyseal regions were flared (Figure 4A and B). The limbs,
especially the forearms (radius and ulna), were considerably
shortened and curved cranially (Figure 4A and B). The femoral
heads and necks were misshapen and the hip joints subluxated
(Figure 4D–F). The length of metacarpi and proximal phalanges
was not constant and varied in and between the limbs
(Figure 4G–H). The spine and skull appeared more normal
even if the vertebral epiphyses were somewhat widened.
Genetic Analyses Map the Chondrodysplasia Locus to
CFA17 and Reveal a Nonsense Mutation in the ITGA10
Gene
A GWAS was performed to map the chondrodysplasia locus in
the NE breed. Nine affected and nine control NEs were genotyped
by using Illumina’s 22K canine SNP chip. A case-control
association analysis revealed a genome-wide significant association
on CFA17 (praw = 7.42610
26, pgenome-wide = 0.013; Fisher’s exact
test) (Figure 5A). At the associated locus, all affected dogs shared
a 2-Mb homozygous haplotype block that spanned from 60 to
62 Mb (CanFam2.0 assembly) (Figure 5B) and contained
altogether 33 genes (Figure 5C). Integrin subunit alpha 10
(ITAG10) was considered the best candidate for mutation
screening since it was known to be expressed on growth plate
chondrocytes [48], and had been shown to affect bone growth in
an Itga10-null mouse model [49].
All 30 ITGA10 exons were sequenced in two affected and two
control NEs. The controls comprised an obligate carrier parent
ITGA10 Mutation in Canine Chondrodysplasia
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and a half-sibling to a dwarf dog. The sequencing revealed
altogether four intronic and five exonic variants (Table 2). Four
exonic variants were synonymous changes but one was a non-
synonymous C to T substitution in exon 16 (c.2083C.T)
(Figure 6A and B), which introduces a premature stop codon
(p.Arg695*) to the encoded protein, integrin subunit alpha 10
(a10) (Figure 6B). The c.2083C.T change segregated with the
phenotype in the four sequenced NEs. The two affected dogs were
homozygous (T/T) for the change, the obligate carrier parent
heterozygous (C/T), and the half-sibling had a wild-type genotype
(C/C). The other eight identified variants did not segregate with
the phenotype but were homozygous in all four sequenced dogs.
The segregation of the c.2083C.T allele was followed further in
affected and healthy NEs (n = 58) (Table S1). In Finnish NEs, all
affected dogs (n = 13) were homozygous for the T allele and all
obligate carriers (n = 4) were heterozygous. Six full-siblings and 22
other relatives had either a heterozygous or a wild-type genotype
(Figure 3A). Similarly, in an additional NE family cohort from the
United States, all affected NEs (n = 4) were homozygous for the T
allele and two known obligate carrier parents were heterozygous.
Five out of seven unaffected family-members were heterozygous
and two were wild-type dogs (Figure 3B).
We then examined whether the c.2083C.T mutation is also
present in the affected KBDs. Genotyping of a cohort of 68 KBDs
revealed a full segregation between the nonsense mutation and the
chondrodysplasia phenotype also in this breed (Table S1). All
affected KBDs (n = 4) were homozygous for the T allele and all
parents of affected dogs (n = 4) were heterozygous. Six out of eight
full-siblings carried the mutated allele, whereas two had a wild-
type genotype (Figure 3C). Out of 52 unaffected relatives, ten
carried the T allele and 42 were homozygous for the wild-type
allele. Collectively, these results revealed a full segregation between
the c.2083C.T mutation and the chondrodysplasia phenotype in
both breeds (p = 2.5610223, n = 126). As an additional support,
the mutation was not found in 192 dogs from 12 other breeds
(Table S1).
Carrier frequency of the c.2083C.T mutation was 24% in a
cohort of 156 randomly selected Finnish NEs and 8% in a
population sample of 287 KBDs. Curiously, all except for one
heterozygous KBD (36 out of 37) could be traced back to the
popular sire that was allegedly a NE-KBD mix (Figure 3C). Out
of all wild-type KBDs, 66% (194 out of 295) could be traced back
to this same sire.
The Integrin Alpha 10 Protein is Absent in the Affected
Tissue
We next studied the potential effects of the c.2083C.T ITGA10
mutation at the mRNA and protein levels. Since the encoded
protein, integrin a10-subunit, is specifically expressed in cartilage-
containing tissues [48], we used cartilaginous bronchial and
tracheal tissue samples from one affected and one control dog.
Sequencing of the full length ITGA10 mRNA verified the presence
of mutation in the affected dog and confirmed the exon-intron
boundaries of the reference sequence (XM_845262.1). In addition,
we detected alternative splicing of exon 24 in the tissue samples of
Figure 2. Size differences between chondrodysplastic and normal Norwegian Elkhounds. Bar plots show the difference of means
concerning (A) height at withers, (B) forearm length and (C) wrist to paw length. Error bars represent the standard error of the mean. Measurements
were taken from 14 unaffected and 6 affected males, and from 11 unaffected and 3 affected females. The wrist to paw length was measured in two
affected females only. *p#0.01, **p#0.001.
doi:10.1371/journal.pone.0075621.g002
Table 1. Body length measurements in affected and healthy
Norwegian Elkhounds.
Sex Status N
Height at
withers
Mean±SD (cm)
Forearm
Mean±SD
(cm)
Wrist to paw
Mean±SD (cm)
Males Unaffected 14 52.361.3 29.161.3 9.460.9
Affected 6 41.664.2 19.864.9 8.261.6
Females Unaffected 11 48.761.4 27.161.8 8.160.9
Affected 3 42.861.0 22.362.1 7.56NA*
*Measured only in two affected females.
doi:10.1371/journal.pone.0075621.t001
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both the affected and control dog. This finding is in accordance
with a previous study that indicated differential splicing of human
and murine ITGA10 transcripts [50]. However, different exons
were reported to be involved in human and mouse; exon 25 was
alternatively spliced out in humans, and in mice, transcription of
exon 26 is extended to the following intron resulting in a truncated
transcript [50]. Unexpectedly, a semi-quantitative PCR analysis
did not reveal observable changes in ITGA10 transcript levels
between the affected and control samples (Figure 7A), which
suggested that the mutated transcript is not readily targeted for
nonsense-mediated mRNA decay (NMD) in the bronchial and
tracheal tissue samples. We examined this further by using real-
time quantitative PCR, which provides a more sensitive quanti-
fication method. The experiment was performed on five different
tissues collected from one affected and one wild-type dog. In the
lung and bronchial tissue, the results were suggestive of a reduced
Figure 3. Chondrodysplasia pedigrees are consistent with autosomal recessive inheritance. (A) A pedigree established around the
affected Norwegian Elkhounds from Finland. Samples and phenotype information were obtained from all siblings in one litter only, otherwise the
phenotypes of full siblings of affected dogs were not known. Denoted are the nine cases and controls that were genotyped using the canine SNP-
chip. (B) A pedigree drawn around four affected Norwegian Elkhounds from the United States. (C) A pedigree of the chondrodysplasia phenotype in
Karelian Bear Dogs. All affected Karelian Bear Dogs have a single popular sire as a common ancestor (arrow). In all three pedigrees, the recessive
c.2083C.T mutation shows full segregation with the chondrodysplasia phenotype. Genotypes are marked with red (T/T), blue (C/T) and black (C/C).
doi:10.1371/journal.pone.0075621.g003
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Figure 4. Radiographic findings in affected dogs. (A) The forearm of an unaffected 5-month-old male Karelian Bear Dog has narrow and even
growth plates (arrows). (B) The forearm of a severely affected 5-month-old male Karelian Bear Dog with markedly short and bowed radius and ulna.
ITGA10 Mutation in Canine Chondrodysplasia
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The growth plates are wide and irregular and metaphyseal flaring can be observed (arrows). (C) The forearm of a 3-year-old affected male Norwegian
Elkhound. The radius is slightly bowed cranially (arrow). (D) Normal hip joints of an unaffected 5-month-old Karelian Bear Dog. The femoral head sits
in its correct position (arrows). (E) Abnormal hip joints of a 5-month-old affected Karelian Bear Dog. The femoral heads are misshapen (white arrow),
femoral necks are abnormally short (arrowhead) and the joints are subluxated (red arrow). (F) Normal hip joints of a less severely affected 3-year-old
Norwegian Elkhound. (G) Normal metacarpal bones and digits of an unaffected 5-month-old Karelian Bear Dog. (H) Distal forelimb of an affected 5-
month-old Karelian Bear Dog with a very short fifth metacarpal bone (arrow). (I) Distal hind limbs of an affected 5-month-old Karelian Bear Dog. Wide
growth plates and metaphyseal flaring are apparent. The proximal phalanx of the third digit of the right hind limb (arrow) and the fifth metatarsal
bone of the left hind limb (arrowhead) are abnormally short. Dogs in images (A) and (B), (D) and (E) and (G)–(I) are littermates.
doi:10.1371/journal.pone.0075621.g004
Figure 5. Results of genome wide association analysis. (A) The chondrodysplasia locus maps to CFA17. The Manhattan plots show both
nominal and permutated p-values of the Fisher’s exact test across all chromosomes. A close-up of CFA17 shows two SNPs, BICF2S23329094 and
BICF2S23345973 that reach genome-wide significance after permutation testing. (B) Genotypes at the CFA17 associated locus reveal a shared 2-Mb
haplotype block in the affected dogs. (C) The critical region contains 33 genes, including ITGA10, which was selected as a primary candidate gene due
to its known expression in the growth plate chondrocytes and involvement in the endochondral ossification process.
doi:10.1371/journal.pone.0075621.g005
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ITGA10 expression in the affected dog but the other tested tissues,
trachea, small intestine and spleen, indicated an opposite effect
(Figure S1). This could be suggestive of tissue-specific NMD,
however, more samples would be needed to confirm this.
We then proceeded to study the effects of the nonsense mutation
at the protein level. The ITGA10 gene product, integrin a10-
subunit, assembles into a ab-heterodimeric cell surface receptor.
The identified p.Arg695* nonsense mutation is predicted to
shorten the 1165-amino-acid a10-subunit by 471 residues from the
carboxyl-terminal end, eliminating the cytosolic tail, the trans-
membrane domain and a significant proportion of the extracel-
lular protein bulk (Figure 6B). To assess the protein level effects,
we performed a western blot analysis using tracheal tissue lysates
and a polyclonal anti-ITGA10 antibody. A strong signal was
present in the control tissue whereas the protein was absent in the
affected dog, and no truncated protein product was detected
(Figure 7B). This indicates a complete loss of protein function in
the affected dog.
Discussion
We have performed a comprehensive genetic study to identify
the cause of the chondrodysplasia phenotype that was described in
the Norwegian Elkhound 30 years ago [30]. Our results indicate
that the disease is caused by a recessive nonsense mutation
(c.2083C.T, p.Arg695*) in the ITGA10 gene. The nonsense
mutation is predicted to eliminate nearly half of the encoded
integrin subunit a10 protein, and we show that the protein is
absent in the affected tissue. As an independent confirmation of
causality, we demonstrate that the same mutation shows full
segregation with a corresponding phenotype in a genetically
Figure 6. A homozygous nonsense mutation in ITGA10. (A) Chromatograms of the mutation position in a wild-type, a carrier and an affected
dog. (B) A schematic representation of ITGA10 gene structure and of a10 protein domains. The protein coding sequence of the canine ITGA10 gene is
composed of 30 exons, and the c.2083C.T change is positioned on exon 16. The a10-subunit is a single pass transmembrane protein with a small
cytosolic domain. The largest part of the protein is located in the extracellular space. The nonsense mutation p.Arg695* is positioned approximately
in the middle of the a10-subunit. SP = signal peptide, TM= transmembrane segment.
doi:10.1371/journal.pone.0075621.g006
Table 2. A summary of the variants found in the mutation
screening ITGA10 exons in two affected and two healthy
Norwegian Elkhounds.
Position Variant Amino acid change Segregation
Intron 2 c.164+47C.A – No
Intron 3 c.274+97T.C – No
Exon 6 c.519T.C p.Asp173Asp.silent No
Intron 8 c.909+8T.G – No
Exon 9 c.1044T.C p.Asp348Asp.silent No
Exon 14 c.1734T.C p.His578His.silent No
Exon 16 c.1938C.G p.Val646Val.silent No
Exon 16 c.2083C.T p.Arg695*.nonsense Yes
Intron 26 c.3108+69T.G – No
The following ITGA10 reference sequences were used in naming variants:
XM_845262.1 (mRNA), XP_850355.1 (protein) and NC_006599.2 (genomic).
doi:10.1371/journal.pone.0075621.t002
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different breed, the KBD. The canine chondrodysplasia pheno-
type implicates an essential role for ITGA10 in endochondral
ossification and reveals a candidate gene for similar conditions in
other species, including human.
ITGA10 represents an excellent candidate gene for chondro-
dysplasia. The encoded integrin subunit a10 belongs to the
integrin family of proteins [51], which constitute a group of
bidirectional cell surface receptors that mediate cells’ interactions
with the surrounding ECM and other cells [52–55]. Altogether
eight a- and 18 b-subunits have been described in vertebrates, and
these combine into 24 different ab-heterodimers that have distinct
ligand binding and signaling properties [52,53,56]. The integrin
a10-subunit assembles into an a10b1 heterodimer [51], which
belongs to the collagen receptor subgroup of integrins, together
with three other b1 integrins, a1b1, a2b1 and a11b1. All four
possess a specific collagen-binding I-domain in their a-subunit
[57–61]. The a10b1 heterodimer was originally identified as a
collagen type II-binding integrin in bovine chondrocytes [51]. In
addition to collagen type II, a10b1 has been shown to bind
laminin and other collagen types as well, and may show preference
to the non-fibrillar collagen types IV and VI [62]. Prior to this
study, no spontaneous disease-causing mutations have been
reported for either ITGA10 or for the b1-subunit gene ITGB1.
A previous study in mice indicated that the a10 protein is
primarily expressed in cartilage chondrocytes [48]. The prenatal
expression of a10 in the developing murine cartilage coincides
with chondrogenesis and collagen type II expression [48]. During
post-natal development, a10 is expressed by chondrocytes
throughout the growth plate cartilage [48]. The major collagen
constituent of the cartilage ECM is collagen type II, and other less
abundant collagen components include types IX, X and XI [63–
65]. Mutations in several different collagen genes are known to
cause various forms of chondrodysplasia and other skeletal
disorders [12,66]. Mutations in the type II procollagen gene
COL2A1 alone cause at least ten different forms of skeletal
dysplasia [3,67]. While many disease mutations are recognized in
collagen genes, they have been rare in collagen-binding receptors.
Chondrodysplasia-causing mutations has been reported only for a
discoidin domain receptor 2 (DDR2) [68–71], which is a receptor
tyrosine kinase that regulates chondrocyte differentiation and
proliferation during endochondral ossification [70,72,73]. Impor-
tantly, our study associates the second collagen-binding receptor
gene to a naturally-occurring inherited chondrodysplasia.
The precise signals that are mediated by the a10b1 receptor
during endochondral ossification are unclear but studies in
induced a10- and b1-deficient mouse models indicate roles in
matrix fibril assembly and chondrocyte proliferation [49,74]. Mice
that lack the integrin a10-subunit gene have been reported to
suffer from mild chondrodysplasia and to present with a slight
reduction in the length of the long bones [49]. The skeleton of the
a10-null mice appeared otherwise normal, apart from a reduction
in the length of tibia and femur to 93-90% when compared to
wild-type mice [49]. The skeletal phenotype of the affected dogs is
considerably more pronounced. The initial characterization of the
NE dwarf phenotype in the 1980’s revealed a generalized skeletal
disorder with significant metaphyseal changes in all growth
centers, especially at the distal metaphyses of the radii and ulnae
[30]. The affected NEs had significantly shorter long bones than
unaffected dogs, bowed front limbs and valgus deformity at the
carpi. Furthermore, ossification of carpal cuboid bones was
delayed, and the vertebral bodies were affected, which caused a
reduction in the length of the torso [30]. Our present clinical
findings are in accordance with the previous phenotypic charac-
terization. However, the radiographic examination of a severely
affected KBD revealed significantly misshapen femoral necks and
heads, which was not reported before.
Similar to the overall skeletal changes, the histological changes
are milder in the a10-null mice than in affected dogs but there are
some shared features [30,49]. The gross morphological appear-
ance of the a10-deficient murine growth plates was reported not to
differ from wild-type mice. However, a more detailed examination
revealed some slight changes, including a reduced number of cell
Figure 7. ITGA10 expression on the RNA and protein level. (A) Semi-quantitative analysis of ITGA10mRNA expression in bronchial and tracheal
tissue samples of an affected NE and an unaffected Australian Kelpie dog. PCR reactions were performed using three cycle numbers, 27, 32 and 37.
Amplification of mRNA fragments was roughly equal in both dogs, which indicated that the mutated transcript is stable and not targeted for
nonsense mediated decay. (B) A western blot analysis of ITGA10 protein expression. A polyclonal anti-ITGA10 antibody was probed against the total
protein lysates from tracheal tissue samples of the affected NE and the unaffected Australian Kelpie. The full-length ITGA10 protein was detected in
the unaffected control dog but not in the affected dog. GAPDH was used as a loading control.
doi:10.1371/journal.pone.0075621.g007
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layers in zone of chondrocyte hypertrophy and some disorgani-
zation of chondrocyte columns in the zone of chondrocyte
proliferation [49]. More pronounced changes were described in
affected NEs [30]. In 10-week-old affected animals, the zone of
chondrocyte proliferation was decreased to half in width,
contained unusual wide bars of ECM and had a disorganized
column formation. Moreover, the disorganization continued to the
columnar structure of the hypertrophic and degenerating zones,
and also to the trabeculae of the metaphyseal spongiosa [30].
Interestingly, both mice and dogs developed misshapen, spherical
chondrocytes, when the normal appearance of the proliferating
chondrocytes is flattened [30,49]. Similar atypical chondrocyte
morphology has been described in b1-deficient growth plates as
well [74]. A targeted inactivation of the ITGB1 gene in murine
cartilage, and the subsequent loss of all b1-integrins, has been
shown to result in frequent perinatal lethality and severe
chondrodysplasia with markedly abnormal growth plate morphol-
ogy [74]. Both a10- and b1-deficient murine growth plates show
reduced collagen fibril density and a cell cycle defect [49,74]. In
accordance with this, an abnormal accentuation of ECM fibril
structure and a decreased width of the proliferative zone were
reported in the growth plates of dwarf NEs [30]. Taken together,
the skeletal defect and histological changes in the a10-deficient
mice offer strong support for the causality of the now identified
canine mutation. However, the severity of the canine phenotype
indicates a more critical role for the a10b1-receptor during
endochondral ossification in larger sized mammals.
We examined the effects of the identified nonsense mutation
both at mRNA and protein levels. Unexpectedly, we were unable
to detect evidence of reduced ITGA10 mRNA expression in all
tested tissues of the affected dog, which might be indicative of
tissue-specific NMD. The NMD is a mechanism that protects cells
from the possible detrimental effects of truncated polypeptides that
result from premature translation termination codons [75].
According to a proposed general mechanism, those premature
stop codons that are at least 50–55 nucleotides upstream from a
39-exon-exon junction are a target of NMD [76]. The p.Arg695*
nonsense change in exon 16 of canine ITGA10 should therefore
elicit the NMD response. However, the process of NMD is still not
completely understood and exceptions to the above mentioned
rule have been reported [77–80]. There is also evidence of tissue
and developmental stage specific regulation of NMD [81–84].
Unfortunately, we had very limited tissue material available (one
case and one control), to confirm the possible tissue-specific NMD.
Moreover, we were not able to collect growth plate cartilage tissue
from affected and unaffected adolescent dogs, which would have
been optimal to determine transcript levels relative to the
phenotype in question. It is a possibility that the mutated
transcript escapes mRNA surveillance, leading to the translation
of a truncated product. However, a truncated protein would likely
be unstable. Accordingly, our immunoblotting experiment re-
vealed an absence of the full length ITGA10 protein, which
indicates a loss of function, and is in accordance with the recessive
canine phenotype. Since heterozygous carrier dogs do not exhibit
a skeletal phenotype, a dominant negative mutation caused by an
aberrant truncated protein product would be unlikely. However,
there is a possibility that the polyclonal antibody we used in the
immunoblotting experiment did not recognize a truncated N-
terminal protein, and therefore further studies would be needed to
clarify the matter.
In strong support of pathogenicity, the nonsense mutation
identified in NEs, was found in another breed, the KBD, that had
the same clinical manifestation. Moreover, the mutation segregat-
ed with the chondrodysplasia phenotype in a separate NE family
cohort from the US. A high mutation carrier frequency of almost
one in every fourth dog was recorded within the Finnish NEs,
whereas the frequency was notably lower in the Finnish KBDs.
The results of our carrier screening suggested that a single popular
KBD sire, that was probably a part NE, if not introduced, at least
highly enriched the frequency of the mutation in KBDs. A simple
genetic test is now offered for NE and KBD breeds to help control
the carrier frequencies and to eradicate the condition from the
breeds.
Our results implicate the ITGA10 gene as a plausible candidate
gene for humans. Although the previously described a10-deficient
mouse model already revealed a mild skeletal phenotype, the more
pronounced chondrodysplastic changes in the larger spontaneous
canine model make ITGA10 a strong causative candidate in
human disproportionate chondrodysplasias. Since the dog is more
close to human in size and physiology, a phenotype of similar
severity would be likely. Currently, the molecular genetic
background is known for many human conditions but there are
those, in which the causative genes are yet to be identified [3]. The
radiographic and histological features of the affected NEs have
been suggested to correspond to the changes found in human
spondylometaphyseal dysplasias [30]. Given the lack of interme-
diate phenotypes in the heterozygous dogs and the likely loss of all
ITGA10 function in affected dogs, the corresponding human
conditions would likely be recessive chondrodysplasias.
In summary, we identify a novel canine chondrodysplasia gene,
ITGA10, which also represents a candidate gene for human
chondrodysplasias. The canine phenotype provides additional
evidence of the critical role of the a10b1 receptor in bone growth,
and offers a large animal model for further functional studies.
Finally, our findings have enabled the development of a genetic
test for the affected breeds.
Materials and Methods
Ethics Statement
All animals used in this study were privately owned pet dogs,
and the owners gave permission for their dogs to be used in the
study. The research was approved by the Animal Ethics
Committee at the State Provincial Office of Southern Finland
(permits: ESLH-2006-08207/Ym-23 and ESHL-2009-07827).
Animals and Samples
The entire study cohort comprised 214 Norwegian Elkhounds,
336 Karelian Bear Dogs and a control cohort of 192 dogs from 12
other breeds (Table S1). The Finnish NE cohort of 45 dogs
included altogether 13 affected NEs from 12 different litters
(Figure 3A). In one litter, samples were received from the affected
dog, both parents and from all six unaffected littermates. Other
samples included two obligate carrier parents and 22 more distant
relatives. An additional NE family cohort of 13 dogs was received
from the United States, comprising four affected dogs from two
litters, two obligate carrier parents, six unaffected littermates and
one other unaffected relative (Figure 3B). The KBD sample
cohort of 68 dogs comprised four affected dogs out of two different
litters, eight full siblings, four obligate carrier parents and 52
relatives. One KBD litter was covered fully, as both parents and all
affected and healthy littermates were sampled (Figure 3C).
Pedigrees were drawn around the affected dogs by using the
GenoPro genealogy software (http://www.genopro.com/) and the
Finnish Kennel Club’s pedigree registry KoiraNet (http://jalostus.
kennelliitto.fi/). Population cohorts were used to estimate
mutation carrier frequencies. In Finnish NEs, a population cohort
of 156 unaffected dogs was randomly selected among those NE
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samples that had been collected for other research projects. In
KBDs, a population cohort of 287 unaffected dogs comprised all
those KBD samples that had been collected before the
chondrodysplasia study was initiated.
Majority of research samples were collected as EDTA-blood.
Three KBD samples and the NE family cohort from the United
States were received as buccal swabs. DNA was extracted from the
whole blood samples by using a semi-automated Chemagen
extraction robot (Chemagen Biopolymer-Technologie AG) and
the buccal swap samples were extracted by using the QiaAmp
DNA Mini Kit (Qiagen). DNA concentrations were determined by
using a ND-1000 UV/Vis Spectrophotometer (NanoDrop Tech-
nologies) and the samples were stored at 220uC until further use.
Body Length Measurements
A set of three body measurements were collected from affected
and normal NEs. Owners were asked to measure the height at
withers, the length of the forearm from elbow to wrist and the
length from wrist to paw (carpal and metacarpal bones) according
to detailed instructions. Measurements were obtained from
altogether 34 dogs, comprising 14 control males, six affected
males, 11 control females and three affected females. The wrist to
paw length was measured in two affected females only. Statistical
analysis on length measurements were performed using PASW
Statistics 18 software (IBM). The Student’s t-test was used when
equality of variances was fulfilled (Levene’s test p was .0.05) and
if not, the Mann-Whitney U-test was applied.
Genome-wide Association Analysis
Nine affected and nine healthy NEs were genotyped using
Illumina’s CanineSNP20 BeadChip of 22,362 validated SNPs.
The nine affected dogs were from different litters. The potential
confounding effects of population stratification were accounted for
by using matched second-degree relatives (half-siblings) or more
distant relatives as genotyping controls (Figure 3A). Genotype
data was filtered using a minor allele frequency of .5%, SNP call
rate of .95% and a sample call rate of .95%. A total of
7679 SNPs were removed for low minor allele frequency and
238 SNPs failed the missingness test. Since the total genotyping
rate was 99.2%, no samples had to be removed for low sample call
rate. No significant deviations were detected from the Hardy-
Weinberg equilibrium with the threshold at p#0.0001. After all
filtering steps, 14,626 SNPs remained for analyses. The Fisher’s
exact test was performed to calculate allelic association between
cases and controls using software package PLINK [85]. Genome-
wide significance was ascertained through phenotype permutation
testing (n = 50,000).
Mutation Screening
Canine ITGA10 (XM_845262.1) sequencing primers (Table
S2) were designed using Primer 3 (http://frodo.wi.mit.edu/
primer3/). PCR reactions were performed in a 20 ml reaction
volume that contained 20 ng of genomic DNA, 16PCR buffer,
2 mM MgCl2, 0.2 mM dNTPs, 0.5 mM of forward- and reverse
primers, 1 M betaine (Sigma-Aldrich) and 1 unit of Biotools DNA
Polymerase. PCR products were run on a 1% agarose gel stained
with GelRed (Biotium, Inc). Sequencing reactions were carried out
using a 37306l DNA Analyzer (Applied Biosystems), and sequence
data was analyzed by using Variant Reporter v1.0 program
(Applied Biosystems). Applied Biosystems’ TaqMan chemistry and
7500 Fast Real-Time PCR instrumentation were used to genotype
the control cohorts. The probe sequence for the wild-type allele
was 59-CACTCACAGAATCGGCGAT-39 and 59-CACTCACA-
GAATCAGCGAT-39 for the mutated allele. Amplification
primers were 59-CTCCTGGCCGCTGGA-39 and 59-GGGCT-
GAGAGTTGCTTAGGA-39, forward and reverse, respectively.
The Taqman genotyping reactions were performed in a 10 ml
reaction volume with 10 ng of genomic DNA, 16TaqMan
genotyping assay and 16Genotyping Master Mix (Applied
Biosystems).
Tissue Samples
One 3-year-old affected male NE was euthanized on owner’s
decision due to aggressive behavior towards humans and other
dogs. Samples from various different tissues were collected
immediately after euthanasia and stabilized in RNAlater (Ambion,
Inc). The stabilized tissue samples were kept in 280uC until
subsequent use. Control tissue samples were obtained from a 2-
year-old male Australian Kelpie that was put down because of
severe epileptic seizures.
RNA Experiments
Total RNA was extracted from tracheal and bronchial tissue
samples of one affected NE and one unaffected Australian Kelpie.
RNA extraction was performed using the RNeasy Mini Kit
(Qiagen). Concentration of RNA samples was determined by using
a ND-1000 UV/Vis Spectrophotometer (NanoDrop Technolo-
gies), and equal amounts of RNA were reverse-transcribed into
cDNA by using the High Capacity RNA-to-cDNA Kit (Applied
Biosystems). The full-length ITGA10 mRNA was sequenced from
the cDNA samples by using primers that were designed to span
multiple exons in order to control for genomic DNA contamina-
tion (Table S2). The mRNA sequencing reactions and data
analysis was carried out as described in methods for mutation
screening.
Semi-quantitative PCR and real-time quantitative PCR (qPCR)
were used to study the levels of ITGA10 mRNA in affected and
control dog. In the semi-quantitative analysis, one of the mRNA
sequencing primer pairs, ITGA10_mRNA_7 (Table S2), was
amplified in equal amounts of the tracheal and bronchial cDNA
samples. Amplifications were performed using three different cycle
numbers (27, 32 and 37) to ensure that a logarithmic amplification
phase was detected. Expression levels were evaluated on 1.5%
agarose gel stained with GelRed (Biotium, Inc). The qPCR
experiment was performed by using two different ITGA10 primer
pairs (Table S2), and the obtained expression data was
normalized against two house-keeping genes, GAPDH and
YWHAZ. The PCR reactions were performed using Applied
Biosystems’ 7500 Fast Real-Time PCR instrumentation and
Roche’s FastStart Universal SYBR Green Master according to
the manufacturers’ instructions. Triplicate samples were used for
all reactions. The efficiencies of the qPCR reactions were
calculated from a seven-point dilutions series and the relative
expression differences were calculated using the comparative
DDCt-method [86].
Protein Expression Analysis
Total protein lysates were prepared for a western blot
experiment from tracheal tissue samples of one affected NE and
one unaffected Australian Kelpie dog. The RNAlater preserved
tissue samples were homogenized on ice using the Pierce T-PER
Tissue Protein Extraction Reagent (Thermo Fisher Scientific) with
Pierce Halt Protease Inhibitor Cocktail (Thermo Fisher Scientific)
added to the extraction buffer. Pierce BCA Protein Assay Kit
(Thermo Fisher Scientific) was used to determine protein
concentration in order to load equal amounts of protein lysates
for 9% SDS-PAGE and subsequent western blotting. A mouse
polyclonal anti-ITGA10 antibody (Sigma-Aldrich #SAB1411763)
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was used as primary antibody in immunoblotting, together with a
mouse monoclonal antibody for GAPDH (Invitrogen #39–8600).
The polyclonal anti-ITGA10 antibody was raised against the full
length ITGA10 and was therefore expected to recognize a possible
truncated protein. The immunoblotting signals were detected by
using a horseradish peroxidase-conjugated anti-mouse IgG anti-
body (GE Healthcare #NA931) and Pierce SuperSignal West
Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific).
Supporting Information
Figure S1 Relative expression levels of ITGA10 mRNA.
The relative expression levels of ITGA10 mRNA were studied
in five different tissues using samples from one affected Norwegian
Elkhound and one unaffected wild-type dog from another breed.
Two primer pairs, (A) ITGA10_q1 and (B) ITGA10_q2, that were
positioned on opposite ends of the canine ITGA10 mRNA were
used to determine relative expression levels. Two tested tissues
(lung and bronchus) showed a clear decrease of ITGA10 expression
in the affected dog. The other tissues (trachea, small intestine and
spleen) showed an increase in the ITGA10 expression in the
affected dog. Error bars represent the standard error of Ct-values.
(TIF)
Table S1 Dogs genotyped for the ITGA10 mutation.
(XLSX)
Table S2 ITGA10 sequencing and qPCR primers.
(XLSX)
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